Submitted by amarin on Sat, 04/06/2024 - 19:30 Home ID Reference 23986 Tags General Releases Page Tags Global News / Press Release News & Media News title New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups